87 results on '"Harbison, C"'
Search Results
2. Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer
3. A multidimensional measure of religious involvement for cancer patients: the Duke Religious Index
4. CA224-047: A randomized, double-blind, phase II/III study of relatlimab (anti–LAG-3) in combination with nivolumab (anti–PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
5. Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study
6. 1302TiP - CA224-047: A randomized, double-blind, phase II/III study of relatlimab (anti–LAG-3) in combination with nivolumab (anti–PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
7. Strain- and Diet-Related Lesion Variability in Aging DBA/2, C57BL/6, and DBA/2xC57BL/6 F1 Mice
8. A Second Domain Wall Parameter Measurable by Lorentz Microscopy
9. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
10. Immunohistochemical Characterization of Large Intestinal Adenocarcinoma in the Rhesus Macaque (Macaca mulatta)
11. Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC)
12. Safety and Response With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Plus Erlotinib in Patients (Pts) With Epidermal Growth Factor Receptor Mutant (EGFR MT) Advanced Non-Small Cell Lung Cancer (NSCLC)
13. Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)
14. First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status
15. Nivolumab (Anti-Pd-1; Bms-936558, Ono-4538) in Combination with Platinum-Based Doublet Chemotherapy (Pt-Dc) or Erlotinib (Erl) in Advanced Non-Small Cell Lung Cancer (Nsclc)
16. Smoking History and Response to Nivolumab in Patients with Advanced Nsclcs
17. 784P - Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study
18. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
19. Meeting Report
20. Strain- and Diet-Related Lesion Variability in Aging DBA/2, C57BL/6, and DBA/2xC57BL/6 F1 Mice.
21. Meeting Report
22. FCGR2A H131R and FCGR3A V158F polymorphism status in mCRC patients treated with single-agent cetuximab (IMCL 0144 and CA225045) or with second-line irinotecan plus cetuximab (EPIC): A pooled statistical analysis.
23. Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
24. Patient selection for cetuximab in NSCLC: A systematic review of candidate predictive biomarkers.
25. Biomarker Analyses in Phase 2 Single-Agent Trials of Dasatinib for Breast Cancer.
26. K-Ras mutation (mut), EGFR-related, and exploratory markers as response predictors of cetuximab in first-line advanced NSCLC: Retrospective analyses of the BMS099 trial
27. High epiregulin (EREG) gene expression plus K-ras wild-type (WT) status as predictors of cetuximab benefit in the treatment of advanced colorectal cancer (ACRC): Results from NCIC CTG CO.17—A phase III trial of cetuximab versus best supportive care (BSC)
28. Immunohistochemical Characterization of Large Intestinal Adenocarcinoma in the Rhesus Macaque (Macaca mulatta).
29. 1229PD - Smoking History and Response to Nivolumab in Patients with Advanced Nsclcs
30. 1054PD - Nivolumab (Anti-Pd-1; Bms-936558, Ono-4538) in Combination with Platinum-Based Doublet Chemotherapy (Pt-Dc) or Erlotinib (Erl) in Advanced Non-Small Cell Lung Cancer (Nsclc)
31. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.
32. Meeting Report: Emerging Respiratory Viral Infections and Nonhuman Primate Case Reports.
33. Meeting Report: Spontaneous Lesions and Diseases in Wild, Captive-Bred, and Zoo-Housed Nonhuman Primates and in Nonhuman Primate Species Used in Drug Safety Studies.
34. Remodeling of yeast genome expression in response to environmental changes.
35. THE TASMAN PULP AND PAPER PROJECT, KAINGAROA, NEW ZEALAND
36. Report on Butter
37. Beasts real and imagined.
38. 1135PDCharacterization of the immune tumor microenvironment (TME) to inform personalized medicine with immuno-oncology (IO) combinations.
39. A distributed subcortical circuit linked to instrumental information-seeking about threat.
40. Asymmetric projection of introspection reveals a behavioural and neural mechanism for interindividual social coordination.
41. Human hippocampus and dorsomedial prefrontal cortex infer and update latent causes during social interaction.
42. Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord.
43. A frontopolar-temporal circuit determines the impact of social information in macaque decision making.
44. Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox.
45. Causal role of a neural system for separating and selecting multidimensional social cognitive information.
46. Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.
47. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
48. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
49. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.
50. Ablation of Hepatic Production of the Acid-Labile Subunit in Bovine-GH Transgenic Mice: Effects on Organ and Skeletal Growth.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.